Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL AI, will be participating in the following upcoming investor conferences:
28th Annual Scotiabank TMT Conference
Date: March 4-5, 2025
Location: Scotiabank Conference Centre, Toronto
Presentation Time: March 5, 12:25 PM ET - 2nd Floor of Scotiabank Conference Centre
The Scotiabank TMT Conference is a premier event bringing together leaders in the technology, media, and telecommunications sectors. This conference provides a platform for companies to showcase their latest innovations and engage with institutional investors through presentations and one-on-one meetings. HEALWELL CEO, Dr. Alexander Dobranowski will be participating in a keynote discussion panel title, "AI and the Digital Health Ecosystem: Building a Smarter Future."
Please contact your Scotiabank representative for further information and to book a 1on1 meeting.
37th Annual ROTH Conference
Date: March 16-18, 2025
Location: The Laguna Cliffs Marriott, Dana Point, California
The ROTH Conference is one of the largest gatherings for small-cap companies in North America, featuring approximately 450 private and public companies in a variety of growth sectors including: Business Services, Consumer, Healthcare, Industrial Growth, Insurance, Resources, Sustainability and Technology, Media & Entertainment. HEALWELL CEO, Dr. Alexander Dobronowski will be participating in 1-on-1 meetings at the conference to connect with investors and discuss the company's innovative AI-powered healthcare solutions and its vision for transforming preventative care.
Please contact your ROTH Capital representative for further information and to book a 1on1 meeting.
Dr. Alexander Dobranowski
Chief Executive Officer
HEALWELL AI Inc.
About HEALWELL AI
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
For more information:
Pardeep S. Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
ir@healwell.ai
| Last Trade: | C$1.48 |
| Daily Change: | 0.03 2.07 |
| Daily Volume: | 368,035 |
| Market Cap: | C$245.500M |
February 26, 2025 February 10, 2025 January 28, 2025 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
